| Ident. | Authors (with country if any) | Title |
|---|
| 000048 (2020) |
M. Liu [République populaire de Chine] ; R E Feng [République populaire de Chine] ; Q. Li [République populaire de Chine] ; H K Zhang [République populaire de Chine] ; Y G Wang [République populaire de Chine] | [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV coronavirus]. |
| 000156 (2020) |
Noah C. Peeri [États-Unis] ; Nistha Shrestha [États-Unis] ; Md Siddikur Rahman [Bangladesh] ; Rafdzah Zaki [Malaisie] ; Zhengqi Tan [États-Unis] ; Saana Bibi [Pakistan] ; Mahdi Baghbanzadeh [Iran] ; Nasrin Aghamohammadi [Malaisie] ; Wenyi Zhang [République populaire de Chine] ; Ubydul Haque [États-Unis] | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| 000187 (2020) |
Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg Doherty | Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment |
| 000222 (2020) |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
| 000284 (2020) |
D. Katterine Bonilla-Aldana | SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis☆ |
| 000356 (2020) |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
| 000398 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000429 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000443 (2020) |
S A Meo [Arabie saoudite] ; A M Alhowikan ; T. Al-Khlaiwi ; I M Meo ; D M Halepoto ; M. Iqbal ; A M Usmani ; W. Hajjar ; N. Ahmed | Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. |
| 000489 (2020) |
Kaihao Liang | Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS |
| 000505 (2020) |
Anwar E. Ahmed [États-Unis] | Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa. |
| 000517 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
| 000544 (2020) |
| Influenza, Measles, SARS, MERS, and Smallpox |
| 000567 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000568 (2020) |
Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran] | Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS. |
| 000677 (2020) |
Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan] | Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV |
| 000716 (2020) |
Xuan Jiang [République populaire de Chine] ; Simon Rayner [Norvège] ; Min-Hua Luo [République populaire de Chine] | Does SARS-CoV-2 has a longer incubation period than SARS and MERS? |
| 000729 (2020) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Ziad A. Memish [Arabie saoudite] | Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV |
| 000744 (2020) |
Sheng Cui [République populaire de Chine] ; Wei Hao [République populaire de Chine] | Deducing the Crystal Structure of MERS-CoV Helicase. |
| 000806 (2020) |
Barry Rockx [Pays-Bas] ; Thijs Kuiken [Pays-Bas] ; Sander Herfst [Pays-Bas] ; Theo Bestebroer [Pays-Bas] ; Mart M. Lamers [Pays-Bas] ; Bas B. Oude Munnink [Pays-Bas] ; Dennis De Meulder [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; Judith Van Den Brand [Pays-Bas] ; Nisreen M A. Okba [Pays-Bas] ; Debby Schipper [Pays-Bas] ; Peter Van Run [Pays-Bas] ; Lonneke Leijten [Pays-Bas] ; Reina Sikkema [Pays-Bas] ; Ernst Verschoor [Pays-Bas] ; Babs Verstrepen [Pays-Bas] ; Willy Bogers [Pays-Bas] ; Jan Langermans [Pays-Bas] ; Christian Drosten [Allemagne] ; Martje Fentener Van Vlissingen [Pays-Bas] ; Ron Fouchier [Pays-Bas] ; Rik De Swart [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] | Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. |
| 000888 (2020) |
Mirae Park ; Ryan S. Thwaites ; Peter J. M. Openshaw | COVID‐19: Lessons from SARS and MERS |
